US Stock MarketDetailed Quotes

EVFM Evofem Biosciences

Watchlist
  • 0.010
  • 0.000-1.90%
15min DelayClose Nov 22 16:00 ET
983.22KMarket Cap0.00P/E (TTM)

Evofem Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
80.58%-459K
23.63%-1.14M
102.49%123K
87.26%-8.97M
97.40%-170K
85.50%-2.36M
94.40%-1.49M
76.39%-4.94M
51.99%-70.41M
69.29%-6.53M
Net income from continuing operations
-103.58%-2.37M
115.79%1.35M
-104.29%-4.81M
169.07%52.98M
74.64%-2.11M
-26.26%66.01M
93.21%-8.56M
92.62%-2.35M
62.62%-76.7M
83.83%-8.34M
Operating gains losses
100.20%143K
-98.36%31K
2,471.43%2.16M
-168.89%-68.15M
-95.26%47K
-376.09%-70.16M
-97.34%1.89M
-95.00%84K
--98.92M
--991K
Depreciation and amortization
-70.99%376K
87.92%-40K
-92.12%59K
-12.95%1.78M
-94.77%67K
418.40%1.3M
-232.40%-331K
182.64%749K
100.00%2.05M
349.47%1.28M
Other non cash items
304.33%1.32M
-52.43%627K
-0.18%564K
-44.37%1.8M
5.77%568K
-320.07%-647K
-11.78%1.32M
-38.45%565K
-20.30%3.24M
-39.12%537K
Change In working capital
201.94%631K
-100.10%-4K
197.31%2.71M
-21.44%4.73M
-6.09%4.29M
-266.85%-619K
189.12%3.85M
-151.60%-2.79M
-43.11%6.02M
-68.64%4.56M
-Change in receivables
30.96%-776K
-114.10%-311K
122.81%1.43M
-186.64%-4.61M
-94.98%584K
79.41%-1.12M
176.39%2.21M
-408.80%-6.28M
198.90%5.32M
581.27%11.64M
-Change in inventory
-12.89%-403K
-86.36%246K
494.95%391K
34.48%2.11M
181.59%758K
-137.46%-357K
129.22%1.8M
-113.11%-99K
7,557.14%1.57M
-149.23%-929K
-Change in prepaid assets
-119.35%-154K
-124.43%-224K
-62.25%573K
41.19%3.66M
-29.74%430K
-83.17%796K
153.53%917K
246.53%1.52M
-81.32%2.59M
-95.43%612K
-Change in payables and accrued expense
1,674.55%1.95M
214.70%320K
-86.32%364K
339.38%5.05M
145.05%2.56M
344.44%110K
44.64%-279K
-35.40%2.66M
-158.51%-2.11M
-367.55%-5.68M
-Change in other current liabilities
127.27%12K
95.61%-35K
92.22%-46K
-9.16%-1.48M
95.73%-46K
-122.92%-44K
-26,466.67%-797K
-26.82%-591K
10.15%-1.35M
-147.02%-1.08M
Cash from discontinued investing activities
Operating cash flow
80.58%-459K
23.63%-1.14M
102.49%123K
87.26%-8.97M
97.40%-170K
85.50%-2.36M
94.40%-1.49M
76.39%-4.94M
51.99%-70.41M
69.29%-6.53M
Investing cash flow
Cash flow from continuing investing activities
-509K
0
-366.67%-14K
98.83%-4K
0
0
99.41%-1K
95.45%-3K
87.32%-341K
33.96%-35K
Net PPE purchase and sale
--0
--0
-366.67%-14K
98.83%-4K
--0
--0
99.41%-1K
95.45%-3K
88.40%-341K
33.96%-35K
Cash from discontinued investing activities
Investing cash flow
---509K
--0
-366.67%-14K
98.83%-4K
--0
--0
99.41%-1K
95.45%-3K
87.32%-341K
33.96%-35K
Financing cash flow
Cash flow from continuing financing activities
-53.32%998K
91.62%1.14M
0
-92.29%4.78M
-77.33%340K
-45.82%2.14M
-98.56%597K
-88.76%1.7M
-31.70%61.94M
-84.80%1.5M
Net issuance payments of debt
-112.34%-262K
-71.08%144K
--0
-20.01%4.49M
-85.07%224K
--2.12M
108.45%498K
-83.60%1.64M
--5.61M
--1.5M
Net common stock issuance
----
----
----
--0
----
----
----
----
-60.38%32.3M
--0
Proceeds from stock option exercised by employees
--0
--0
--0
-98.85%290K
--116K
-99.67%14K
-99.53%99K
--61K
5,433.11%25.23M
--0
Net other financing activities
--0
----
----
----
----
----
----
----
7.32%-1.2M
--0
Cash from discontinued financing activities
Financing cash flow
-53.32%998K
91.62%1.14M
--0
-92.29%4.78M
-77.33%340K
-45.82%2.14M
-98.56%597K
-88.76%1.7M
-31.70%61.94M
-84.80%1.5M
Net cash flow
Beginning cash position
8.81%692K
-55.08%689K
-87.86%580K
-64.85%4.78M
-95.83%410K
-97.14%636K
-80.16%1.53M
-64.85%4.78M
-81.19%13.59M
-60.69%9.84M
Current changes in cash
113.27%30K
100.33%3K
103.36%109K
52.38%-4.2M
103.36%170K
98.18%-226K
-106.18%-898K
44.64%-3.24M
84.98%-8.81M
55.76%-5.07M
End cash Position
76.10%722K
8.81%692K
-55.08%689K
-87.86%580K
-87.86%580K
-95.83%410K
-97.14%636K
-80.16%1.53M
-64.85%4.78M
-64.85%4.78M
Free cash flow
80.58%-459K
23.68%-1.14M
102.21%109K
87.32%-8.97M
97.41%-170K
85.56%-2.36M
94.43%-1.5M
76.45%-4.94M
52.71%-70.75M
69.20%-6.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 80.58%-459K23.63%-1.14M102.49%123K87.26%-8.97M97.40%-170K85.50%-2.36M94.40%-1.49M76.39%-4.94M51.99%-70.41M69.29%-6.53M
Net income from continuing operations -103.58%-2.37M115.79%1.35M-104.29%-4.81M169.07%52.98M74.64%-2.11M-26.26%66.01M93.21%-8.56M92.62%-2.35M62.62%-76.7M83.83%-8.34M
Operating gains losses 100.20%143K-98.36%31K2,471.43%2.16M-168.89%-68.15M-95.26%47K-376.09%-70.16M-97.34%1.89M-95.00%84K--98.92M--991K
Depreciation and amortization -70.99%376K87.92%-40K-92.12%59K-12.95%1.78M-94.77%67K418.40%1.3M-232.40%-331K182.64%749K100.00%2.05M349.47%1.28M
Other non cash items 304.33%1.32M-52.43%627K-0.18%564K-44.37%1.8M5.77%568K-320.07%-647K-11.78%1.32M-38.45%565K-20.30%3.24M-39.12%537K
Change In working capital 201.94%631K-100.10%-4K197.31%2.71M-21.44%4.73M-6.09%4.29M-266.85%-619K189.12%3.85M-151.60%-2.79M-43.11%6.02M-68.64%4.56M
-Change in receivables 30.96%-776K-114.10%-311K122.81%1.43M-186.64%-4.61M-94.98%584K79.41%-1.12M176.39%2.21M-408.80%-6.28M198.90%5.32M581.27%11.64M
-Change in inventory -12.89%-403K-86.36%246K494.95%391K34.48%2.11M181.59%758K-137.46%-357K129.22%1.8M-113.11%-99K7,557.14%1.57M-149.23%-929K
-Change in prepaid assets -119.35%-154K-124.43%-224K-62.25%573K41.19%3.66M-29.74%430K-83.17%796K153.53%917K246.53%1.52M-81.32%2.59M-95.43%612K
-Change in payables and accrued expense 1,674.55%1.95M214.70%320K-86.32%364K339.38%5.05M145.05%2.56M344.44%110K44.64%-279K-35.40%2.66M-158.51%-2.11M-367.55%-5.68M
-Change in other current liabilities 127.27%12K95.61%-35K92.22%-46K-9.16%-1.48M95.73%-46K-122.92%-44K-26,466.67%-797K-26.82%-591K10.15%-1.35M-147.02%-1.08M
Cash from discontinued investing activities
Operating cash flow 80.58%-459K23.63%-1.14M102.49%123K87.26%-8.97M97.40%-170K85.50%-2.36M94.40%-1.49M76.39%-4.94M51.99%-70.41M69.29%-6.53M
Investing cash flow
Cash flow from continuing investing activities -509K0-366.67%-14K98.83%-4K0099.41%-1K95.45%-3K87.32%-341K33.96%-35K
Net PPE purchase and sale --0--0-366.67%-14K98.83%-4K--0--099.41%-1K95.45%-3K88.40%-341K33.96%-35K
Cash from discontinued investing activities
Investing cash flow ---509K--0-366.67%-14K98.83%-4K--0--099.41%-1K95.45%-3K87.32%-341K33.96%-35K
Financing cash flow
Cash flow from continuing financing activities -53.32%998K91.62%1.14M0-92.29%4.78M-77.33%340K-45.82%2.14M-98.56%597K-88.76%1.7M-31.70%61.94M-84.80%1.5M
Net issuance payments of debt -112.34%-262K-71.08%144K--0-20.01%4.49M-85.07%224K--2.12M108.45%498K-83.60%1.64M--5.61M--1.5M
Net common stock issuance --------------0-----------------60.38%32.3M--0
Proceeds from stock option exercised by employees --0--0--0-98.85%290K--116K-99.67%14K-99.53%99K--61K5,433.11%25.23M--0
Net other financing activities --0----------------------------7.32%-1.2M--0
Cash from discontinued financing activities
Financing cash flow -53.32%998K91.62%1.14M--0-92.29%4.78M-77.33%340K-45.82%2.14M-98.56%597K-88.76%1.7M-31.70%61.94M-84.80%1.5M
Net cash flow
Beginning cash position 8.81%692K-55.08%689K-87.86%580K-64.85%4.78M-95.83%410K-97.14%636K-80.16%1.53M-64.85%4.78M-81.19%13.59M-60.69%9.84M
Current changes in cash 113.27%30K100.33%3K103.36%109K52.38%-4.2M103.36%170K98.18%-226K-106.18%-898K44.64%-3.24M84.98%-8.81M55.76%-5.07M
End cash Position 76.10%722K8.81%692K-55.08%689K-87.86%580K-87.86%580K-95.83%410K-97.14%636K-80.16%1.53M-64.85%4.78M-64.85%4.78M
Free cash flow 80.58%-459K23.68%-1.14M102.21%109K87.32%-8.97M97.41%-170K85.56%-2.36M94.43%-1.5M76.45%-4.94M52.71%-70.75M69.20%-6.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data